Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Editorial Comment.

Pavlovich CP.

J Urol. 2018 Apr 27. pii: S0022-5347(18)43037-6. doi: 10.1016/j.juro.2018.02.3113. [Epub ahead of print] No abstract available.

PMID:
29705254
2.

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG.

J Clin Oncol. 2018 Feb 1;36(4):414-424. doi: 10.1200/JCO.2017.74.1173. Epub 2017 Dec 13.

PMID:
29236593
3.

Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.

Druskin SC, Tosoian JJ, Young A, Collica S, Srivastava A, Ghabili K, Macura KJ, Carter HB, Partin AW, Sokoll LJ, Ross AE, Pavlovich CP.

BJU Int. 2018 Apr;121(4):619-626. doi: 10.1111/bju.14098. Epub 2018 Jan 9.

PMID:
29232037
4.

Prostate MRI prior to radical prostatectomy: effects on nerve sparing and pathological margin status.

Druskin SC, Liu JJ, Young A, Feng Z, Dianat SS, Ludwig WW, Trock BJ, Macura KJ, Pavlovich CP.

Res Rep Urol. 2017 Apr 18;9:55-63. doi: 10.2147/RRU.S128499. eCollection 2017.

5.

Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance.

Tosoian JJ, Patel HD, Mamawala M, Landis P, Wolf S, Elliott DJ, Epstein JI, Carter HB, Ross AE, Sokoll LJ, Pavlovich CP.

Prostate Cancer Prostatic Dis. 2017 Sep;20(3):339-342. doi: 10.1038/pcan.2017.16. Epub 2017 Apr 18.

6.

Extraperitoneal Robot-Assisted Radical Prostatectomy: Indications, Technique and Outcomes.

Semerjian A, Pavlovich CP.

Curr Urol Rep. 2017 Jun;18(6):42. doi: 10.1007/s11934-017-0689-4. Review.

PMID:
28417427
7.

Urinary continence recovery after radical prostatectomy - anatomical/reconstructive and nerve-sparing techniques to improve outcomes.

Pavlovich CP, Rocco B, Druskin SC, Davis JW.

BJU Int. 2017 Aug;120(2):185-196. doi: 10.1111/bju.13852. Epub 2017 Apr 17. Review.

PMID:
28319318
8.

Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.

An JY, Ball MW, Gorin MA, Hong JJ, Johnson MH, Pavlovich CP, Allaf ME, Pierorazio PM.

Urology. 2017 Feb;100:151-157. doi: 10.1016/j.urology.2016.10.047. Epub 2016 Nov 23.

9.

The History of Prostate Cancer From Antiquity: Review of Paleopathological Studies.

Ghabili K, Tosoian JJ, Schaeffer EM, Pavlovich CP, Golzari SE, Khajir G, Andreas D, Benzon B, Vuica-Ross M, Ross AE.

Urology. 2016 Nov;97:8-12. doi: 10.1016/j.urology.2016.08.032. Epub 2016 Aug 31. Review. No abstract available.

PMID:
27591810
10.

Editorial Comment.

Patel HD, Pavlovich CP.

J Urol. 2016 Oct;196(4):1006-7. doi: 10.1016/j.juro.2016.04.116. Epub 2016 Jul 15. No abstract available.

PMID:
27424938
11.

Editorial Comment.

Pavlovich CP.

Urology. 2016 Aug;94:137. doi: 10.1016/j.urology.2016.02.064. Epub 2016 Jun 28. No abstract available.

PMID:
27370779
12.

Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.

Tosoian JJ, Chappidi M, Feng Z, Humphreys EB, Han M, Pavlovich CP, Epstein JI, Partin AW, Trock BJ.

BJU Int. 2017 May;119(5):676-683. doi: 10.1111/bju.13573. Epub 2016 Jul 29.

13.

Medical hospitalizations in prostate cancer survivors.

Gnanaraj J, Balakrishnan S, Umar Z, Antonarakis ES, Pavlovich CP, Wright SM, Khaliq W.

Med Oncol. 2016 Jul;33(7):81. doi: 10.1007/s12032-016-0796-y. Epub 2016 Jun 20.

PMID:
27324503
14.

Diagnosing and Treating Inflammatory Myofibroblastic Tumor of the Bladder.

Alam R, Johnson MH, Caldwell T, Pavlovich CP, Bivalacqua TJ, Tosoian JJ.

Case Rep Urol. 2016;2016:5724020. doi: 10.1155/2016/5724020. Epub 2016 May 18.

15.

Assessing Cancer Risk on Novel 29 MHz Micro-Ultrasound Images of the Prostate: Creation of the Micro-Ultrasound Protocol for Prostate Risk Identification.

Ghai S, Eure G, Fradet V, Hyndman ME, McGrath T, Wodlinger B, Pavlovich CP.

J Urol. 2016 Aug;196(2):562-9. doi: 10.1016/j.juro.2015.12.093. Epub 2016 Jan 12.

PMID:
26791931
16.

Nightly sildenafil use after radical prostatectomy has adverse effects on urinary convalescence: Results from a randomized trial of nightly vs on-demand dosing regimens.

Hyndman ME, Bivalacqua TJ, Mettee LZ, Su LM, Trock BJ, Pavlovich CP.

Can Urol Assoc J. 2015 Nov-Dec;9(11-12):414-9. doi: 10.5489/cuaj.3169. Epub 2015 Nov 9. Erratum in: Can Urol Assoc J. 2016 Jan-Feb;10(1-2):E81.

17.

Urinary Biomarkers for Prostate Cancer.

Tosoian JJ, Ross AE, Sokoll LJ, Partin AW, Pavlovich CP.

Urol Clin North Am. 2016 Feb;43(1):17-38. doi: 10.1016/j.ucl.2015.08.003. Review.

PMID:
26614026
18.

Extent of renal vein invasion influences prognosis in patients with renal cell carcinoma.

Ball MW, Gorin MA, Harris KT, Curtiss KM, Netto GJ, Pavlovich CP, Pierorazio PM, Allaf ME.

BJU Int. 2016 Jul;118(1):112-7. doi: 10.1111/bju.13349. Epub 2015 Nov 14.

19.

Inguinal Hernia Repair During Extraperitoneal Robot-Assisted Laparoscopic Radical Prostatectomy.

Ludwig WW, Sopko NA, Azoury SC, Dhanasopon A, Mettee L, Dwarakanath A, Steele KE, Nguyen HT, Pavlovich CP.

J Endourol. 2016 Feb;30(2):208-11. doi: 10.1089/end.2015.0393. Epub 2015 Nov 4.

PMID:
26414558
20.

Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.

Gorin MA, Rowe SP, Baras AS, Solnes LB, Ball MW, Pierorazio PM, Pavlovich CP, Epstein JI, Javadi MS, Allaf ME.

Eur Urol. 2016 Mar;69(3):413-6. doi: 10.1016/j.eururo.2015.08.056. Epub 2015 Sep 18.

PMID:
26386607
21.

¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer.

Rowe SP, Gage KL, Faraj SF, Macura KJ, Cornish TC, Gonzalez-Roibon N, Guner G, Munari E, Partin AW, Pavlovich CP, Han M, Carter HB, Bivalacqua TJ, Blackford A, Holt D, Dannals RF, Netto GJ, Lodge MA, Mease RC, Pomper MG, Cho SY.

J Nucl Med. 2015 Jul;56(7):1003-1010. doi: 10.2967/jnumed.115.154336. Epub 2015 Jun 11.

22.

Safety of minimally invasive radical prostatectomy in patients with prior abdominopelvic or inguinal surgery.

Ball MW, Reese AC, Mettee LZ, Pavlovich CP.

J Endourol. 2015 Feb;29(2):192-7. doi: 10.1089/end.2014.0449. Epub 2014 Oct 7.

23.

Pathological characteristics and radiographic correlates of complex renal cysts.

Reese AC, Johnson PT, Gorin MA, Pierorazio PM, Allaf ME, Fishman EK, Netto GJ, Pavlovich CP.

Urol Oncol. 2014 Oct;32(7):1010-6. doi: 10.1016/j.urolonc.2014.02.022. Epub 2014 Jul 9.

24.

Grade heterogeneity in small renal masses: potential implications for renal mass biopsy.

Ball MW, Bezerra SM, Gorin MA, Cowan M, Pavlovich CP, Pierorazio PM, Netto GJ, Allaf ME.

J Urol. 2015 Jan;193(1):36-40. doi: 10.1016/j.juro.2014.06.067. Epub 2014 Jun 21.

PMID:
24960470
25.

Reply: To PMID 24094657.

Pavlovich CP.

Urology. 2013 Dec;82(6):1354. doi: 10.1016/j.urology.2013.06.071. Epub 2013 Oct 3. No abstract available.

PMID:
24094661
26.

Urinary outcomes are significantly affected by nerve sparing quality during radical prostatectomy.

Kaye DR, Hyndman ME, Segal RL, Mettee LZ, Trock BJ, Feng Z, Su LM, Bivalacqua TJ, Pavlovich CP.

Urology. 2013 Dec;82(6):1348-53. doi: 10.1016/j.urology.2013.06.067. Epub 2013 Oct 3.

PMID:
24094657
27.

Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo.

Pavlovich CP, Levinson AW, Su LM, Mettee LZ, Feng Z, Bivalacqua TJ, Trock BJ.

BJU Int. 2013 Oct;112(6):844-51. doi: 10.1111/bju.12253. Epub 2013 Aug 13.

28.

Laparoscopic and robotic radical prostatectomy outcomes in obese and extremely obese men.

Sundi D, Reese AC, Mettee LZ, Trock BJ, Pavlovich CP.

Urology. 2013 Sep;82(3):600-5. doi: 10.1016/j.urology.2013.05.013. Epub 2013 Jul 13.

29.

Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experience.

Pierorazio PM, Mullins JK, Ross AE, Hyams ES, Partin AW, Han M, Walsh PC, Schaeffer EM, Pavlovich CP, Allaf ME, Bivalacqua TJ.

BJU Int. 2013 Jul;112(1):45-53. doi: 10.1111/j.1464-410X.2012.11767.x.

30.

High-resolution transrectal ultrasound: pilot study of a novel technique for imaging clinically localized prostate cancer.

Pavlovich CP, Cornish TC, Mullins JK, Fradin J, Mettee LZ, Connor JT, Reese AC, Askin FB, Luck R, Epstein JI, Burke HB.

Urol Oncol. 2014 Jan;32(1):34.e27-32. doi: 10.1016/j.urolonc.2013.01.006. Epub 2013 Apr 2.

PMID:
23558161
31.

Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer.

Pierorazio PM, Mullins JK, Eifler JB, Voth K, Hyams ES, Han M, Pavlovich CP, Bivalacqua TJ, Partin AW, Allaf ME, Schaeffer EM.

BJU Int. 2013 Oct;112(6):751-7. doi: 10.1111/j.1464-410X.2012.11757.x. Epub 2013 Jan 28.

32.

Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy.

Pierorazio PM, Ross AE, Lin BM, Epstein JI, Han M, Walsh PC, Partin AW, Pavlovich CP, Schaeffer EM.

BJU Int. 2012 Oct;110(8):1122-8. doi: 10.1111/j.1464-410X.2012.10986.x. Epub 2012 Feb 28.

33.

Whole genome microarray of the major pelvic ganglion after cavernous nerve injury: new insights into molecular profile changes after nerve injury.

Calenda G, Strong TD, Pavlovich CP, Schaeffer EM, Burnett AL, Yu W, Davies KP, Bivalacqua TJ.

BJU Int. 2012 May;109(10):1552-64. doi: 10.1111/j.1464-410X.2011.10705.x. Epub 2012 Feb 2.

34.

Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center.

Albadine R, Hyndman ME, Chaux A, Jeong JY, Saab S, Tavora F, Epstein JI, Gonzalgo ML, Pavlovich CP, Netto GJ.

Hum Pathol. 2012 Feb;43(2):254-60. doi: 10.1016/j.humpath.2011.04.029. Epub 2011 Aug 4.

PMID:
21820147
35.

Comparison of extraperitoneal and transperitoneal pelvic lymph node dissection during minimally invasive radical prostatectomy.

Mullins JK, Hyndman ME, Mettee LZ, Pavlovich CP.

J Endourol. 2011 Dec;25(12):1883-7. doi: 10.1089/end.2011.0209. Epub 2011 Sep 8.

PMID:
21749195
36.

Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy.

Pierorazio PM, Lin BM, Mullins JK, Hyndman ME, Schaeffer EM, Han M, Partin AW, Pavlovich CP.

Urol Oncol. 2013 Jul;31(5):589-94. doi: 10.1016/j.urolonc.2011.05.002. Epub 2011 Jun 12.

PMID:
21664838
37.

Pelvic lymph node dissection is associated with symptomatic venous thromboembolism risk during laparoscopic radical prostatectomy.

Eifler JB, Levinson AW, Hyndman ME, Trock BJ, Pavlovich CP.

J Urol. 2011 May;185(5):1661-5. doi: 10.1016/j.juro.2010.12.044. Epub 2011 Mar 21.

PMID:
21419428
38.

Incidence and risk factors for inguinal and incisional hernia after laparoscopic radical prostatectomy.

Lin BM, Hyndman ME, Steele KE, Feng Z, Trock BJ, Schweitzer MA, Pavlovich CP.

Urology. 2011 Apr;77(4):957-62. doi: 10.1016/j.urology.2010.12.011. Epub 2011 Feb 18.

PMID:
21333335
39.

Prostate size is not associated with recovery of sexual function after minimally invasive radical prostatectomy.

Ward NT, Parsons JK, Levinson AW, Bagga HS, Mettee LZ, Su LM, Pavlovich CP.

Urology. 2011 Apr;77(4):952-6. doi: 10.1016/j.urology.2010.09.053. Epub 2010 Dec 31.

PMID:
21195466
40.

Is a return to baseline sexual function possible? An analysis of sexual function outcomes following laparoscopic radical prostatectomy.

Levinson AW, Lavery HJ, Ward NT, Su LM, Pavlovich CP.

World J Urol. 2011 Feb;29(1):29-34. doi: 10.1007/s00345-010-0616-5. Epub 2010 Nov 24.

PMID:
21107844
41.

Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching.

Magheli A, Gonzalgo ML, Su LM, Guzzo TJ, Netto G, Humphreys EB, Han M, Partin AW, Pavlovich CP.

BJU Int. 2011 Jun;107(12):1956-62. doi: 10.1111/j.1464-410X.2010.09795.x. Epub 2010 Nov 2.

42.

The learning curve for laparoscopic radical prostatectomy: an international multicenter study.

Secin FP, Savage C, Abbou C, de La Taille A, Salomon L, Rassweiler J, Hruza M, Rozet F, Cathelineau X, Janetschek G, Nassar F, Turk I, Vanni AJ, Gill IS, Koenig P, Kaouk JH, Martinez Pineiro L, Pansadoro V, Emiliozzi P, Bjartell A, Jiborn T, Eden C, Richards AJ, Van Velthoven R, Stolzenburg JU, Rabenalt R, Su LM, Pavlovich CP, Levinson AW, Touijer KA, Vickers A, Guillonneau B.

J Urol. 2010 Dec;184(6):2291-6. doi: 10.1016/j.juro.2010.08.003. Epub 2010 Oct 16.

43.

Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status.

Fujita K, Ewing CM, Isaacs WB, Pavlovich CP.

Int J Cancer. 2011 Jul 15;129(2):424-32. doi: 10.1002/ijc.25705. Epub 2010 Nov 16.

44.

Comparison of validated instruments measuring sexual function in men.

Levinson AW, Ward NT, Sanda MG, Mettee LZ, Wei JT, Su LM, Litwin MS, Pavlovich CP.

Urology. 2010 Aug;76(2):380-6. doi: 10.1016/j.urology.2010.04.033. Epub 2010 Jun 22.

PMID:
20573377
45.

Renal artery pseudoaneurysm after partial nephrectomy.

Gupta AD, Semins MJ, Marx JK, Pavlovich CP.

J Urol. 2010 Jun;183(6):2390-1. doi: 10.1016/j.juro.2010.03.070. Epub 2010 Apr 18. No abstract available.

PMID:
20403611
46.

Pelvic node dissection in prostate cancer: extended, limited, or not at all?

Hyndman ME, Mullins JK, Pavlovich CP.

Curr Opin Urol. 2010 May;20(3):211-7. doi: 10.1097/MOU.0b013e328338405d. Review.

PMID:
20224412
47.

Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy.

Schaeffer EM, Guzzo TJ, Furge KA, Netto G, Westphal M, Dykema K, Yang X, Zhou M, Teh BT, Pavlovich CP.

BJU Int. 2010 Jul;106(1):62-5. doi: 10.1111/j.1464-410X.2009.09139.x. Epub 2009 Dec 11.

48.

Horseshoe kidney with giant hydronephrosis secondary to ureteropelvic junction obstruction.

Margreiter M, Hernandez DJ, Lang EK, Pavlovich CP.

J Urol. 2010 Jan;183(1):329. doi: 10.1016/j.juro.2009.09.069. No abstract available.

PMID:
19914649
49.

Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia.

Fujita K, Ewing CM, Getzenberg RH, Parsons JK, Isaacs WB, Pavlovich CP.

Prostate. 2010 Apr 1;70(5):473-81. doi: 10.1002/pros.21081.

50.

Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance.

Fujita K, Landis P, McNeil BK, Pavlovich CP.

J Urol. 2009 Dec;182(6):2664-9. doi: 10.1016/j.juro.2009.08.044.

PMID:
19836757

Supplemental Content

Loading ...
Support Center